MedPath
TGA Approval

EXELON rivastigmine 4.5mg (as hydrogen tartrate) capsule blister pack (71447)

71447

EXELON rivastigmine 4.5mg (as hydrogen tartrate) capsule blister pack

Novartis Pharmaceuticals Australia Pty Ltd

June 6, 2000

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/53ca1a77b214caedfc173dbb551eabcc.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/069f63d809932152fdbdb5d480ff1e04.pdf

Active Ingredients

rivastigmine hydrogen tartrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EXELON rivastigmine 4.5mg (as hydrogen tartrate) capsule blister pack (71447) - TGA 批准文号 | MedPath